Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

Melanoma, a skin cancer associated with high mortality rates, is highly radio- and chemotherapy resistant but can also be very immunogenic. These circumstances have led to a recent surge in research into therapies aiming to boost anti-tumor immune responses in cancer patients. Among these immunother...

Celý popis

Podrobná bibliografie

Vydáno v:	Frontiers in oncology Ročník 8; s. 86
Hlavní autoři:	Seidel, Judith A., Otsuka, Atsushi, Kabashima, Kenji
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 28.03.2018
Témata:	biomarkers cancer immune checkpoint inhibitors immunotherapy melanoma Oncology side effects mode of action biomarkers immunotherapy melanoma side effects cancer immune checkpoint inhibitors
ISSN:	2234-943X, 2234-943X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!